- Home
- MTRX vs NERV Comparison
MTRX vs NERV Comparison
Compare MTRX & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTRX | NERV |
|---|---|---|
| Founded | 1984 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 311.9M | 269.6M |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MTRX | NERV |
|---|---|---|
| Price | $10.20 | $7.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $17.00 | $7.00 |
| AVG Volume (30 Days) | ★ 204.3K | 191.4K |
| Earning Date | 05-06-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $769,286,000.00 | $41,175,600.00 |
| Revenue This Year | $18.83 | N/A |
| Revenue Next Year | $9.35 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.64 | N/A |
| 52 Week Low | $9.33 | $1.15 |
| 52 Week High | $16.11 | $12.46 |
Technical Indicators
Market Signals| Indicator | MTRX | NERV |
|---|---|---|
| Relative Strength Index (RSI) | 31.72 | 64.59 |
| Support Level | N/A | $5.34 |
| Resistance Level | $12.75 | $12.46 |
| Average True Range (ATR) | 0.43 | 0.71 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 4.72 | 70.37 |
Price Performance
Historical ComparisonAbout MTRX Matrix Service Company
Matrix Service Co provides engineering, fabrication, construction, maintenance, and repair services prominently to the energy and industrial markets. The company operates through three main segments: Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities. These segments cover services like building and maintaining storage tanks and terminals, supporting power delivery and new power generation projects including renewables, as well as plant maintenance and turnarounds for refining and petrochemical industries. Matrix generates revenue by delivering these services to clients in oil, gas, power, and petrochemical sectors across North America and internationally.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.